|Day Low/High||18.98 / 19.31|
|52 Wk Low/High||16.58 / 32.80|
A California judge has slashed the punitive damages against Bayer in Roundup lawsuit.
San Francisco judge appears ready to overturn bulk of $289 million verdict against Bayer's Monsanto unit
U.S. stocks end near the day's lows amid concern Turkey's financial crisis could spread.
Turkey's lira fell to a fresh all-time low against the dollar overnight, extending its losses since July past 51%, as the country's economic crisis threatened to spillover into markets all over the world.
U.S. stock futures fall on Monday as Turkey's economic crisis escalates; Saudi Arabia's sovereign wealth fund is looking to invest in Tesla, a report says; Bayer plunges after subsidiary Monsanto loses 'Roundup' cancer trial.
Bayer fell the most in 15 years Monday after a California jury said its Monsanto subsidiary must pay former school groundskeeper Dewayne Johnson $289 million in damages for the cancer he contracted from the chemical group's 'Roundup' weedkiller.
Tech stocks are holding up stocks in Europe and pacing early gains for U.S. equity futures as yesterday's record close for the Nasdaq revives sector bulls amid ongoing concerns for global trade and growth.
In a Tuesday speech at the Boao Forum for Asia Chinese President Xi Jinping spoke of increasing imports, lowering foreign-ownership limits on manufacturing and expanding protection to intellectual property.
The FDA approved 11 different hematological treatments this year after approving 11 in the previous two years combined.
Bayer, which has agreed to buy U.S. seeds maker Monsanto, dipped more than 3% after cutting its outlook for drugs sales and warning of difficult times in U.S. consumer health.
European markets pulled down by quarterly earnings at bank.
The German plastics maker gained 6% after posting a 50% Ebitda increase and announcing a share buyback, handing Bayer more firepower to fund its Monsanto takeover.
Sale should help Bayer's $66 billion takeover of Monsanto
Investors await Tesla's earnings report on Wednesday.
Tesla must find some external green.
The European Commission said Bayer wants to avoid a lengthy review.
Poor earnings and an FDA gut-punch to the tobacco industry sank markets
A string of earnings disappointments and poor economic data hit markets.
Bayer says Monsanto acquisition 'on track'.
Global equity rally takes a breather.
Bank and commodity stocks dragged European benchmarks lower Tuesday as mining stocks pared Monday's gains and the second-quarter earnings season got underway.
The Berkeley site, which includes Bayer's global biotechnology development and product supply organizations, is the company's single plant that manufactures and distributes its Hemophilia A treatments
The first confirmed case of the plague this year was diagnosed in June when a 63-year-old man contracted the disease.
The biggest U.S. grocer wants winter melons to taste just as sweet as the summer ones.
European benchmarks rose Tuesday as fallers from the previous session paired losses and concerns over political risks receded, in favor of a renewed focus on economic data and monetary policy.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.